Salmon pancreas disease vaccine (recombinant DNA plasmid)

This medicine is authorised for use in the European Union.


Clynav is a veterinary vaccine used to protect Atlantic salmon against pancreas disease caused by salmonid alphavirus subtype 3 (SAV3). Pancreas disease in Atlantic salmon can reduce weight gain, leads to damage of the heart, pancreas and skeletal muscle, and may cause death.

The active substance in Clynav is a DNA plasmid (a small piece of DNA) containing the genetic code for making proteins found in salmon pancreas disease virus (SPDV).

This EPAR was last updated on 25/09/2020

Authorisation details

Product details
Agency product number
Active substance
pUK-SPDV-poly2#1 DNA plasmid coding for salmon pancreas disease virus proteins
International non-proprietary name (INN) or common name
Salmon pancreas disease vaccine (recombinant DNA plasmid)
Atlantic salmon
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Elanco GmbH
Date of issue of marketing authorisation valid throughout the European Union
Contact address

Heinz-Lohmann-Str 4
27472 Cuxhaven

Product information

27/03/2020 Clynav - EMEA/V/C/002390 - II/0010

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Immunologicals for Atlantic salmon

Therapeutic indication

For the active immunisation of Atlantic salmon to reduce impaired daily weight gain, and reduce mortality, and cardiac, pancreatic and skeletal muscle lesions caused by pancreas disease following infection with salmonid alphavirus subtype 3 (SAV3).

Assessment history

Related content

How useful was this page?

Add your rating